Evidence map›Paper›PMID 38384361›Full record

ArticleFrontiers in genetics2023

Influence of

Ruixue Xu, Zhaorui Liu, Hanyun Li, Linlin Luo, Yi Zheng, Fuqin Mu, Yujia Liu, Weixin Zhang, Ying Zhang, Jianli Wang and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. The dual role of PCDH9 in tumors, neurological and developmental diseases.Medical oncology (Northwood, London, England) · 2025
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 3 countries.

Ruixue Xu *School of Public Health, Binzhou Medical University, Yantai, China.
Zhaorui Liu *NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University Sixth Hospital, Peking University Institute of Mental Health, Beijing, China.
Hanyun Li *Cheeloo College of Medicine, Shandong University, Jinan, China.
Linlin Luo *Department of Hematology, Tai'an City Central Hospital of Qingdao University, Tai'an, China.
Yi ZhengSchool of Mental Health, Jining Medical University, Jining, China.
Fuqin MuSchool of Mental Health, Jining Medical University, Jining, China.
Yujia LiuMelbourne School of Psychological Sciences, The University of Melbourne, Melbourne, VIC, Australia.
Weixin ZhangSchool of Clinical Medicine, Jining Medical University, Jining, China.
Ying ZhangSchool of Public Health, University of Sydney, Sydney, NSW, Australia.
Jianli WangSchool of Mental Health, Jining Medical University, Jining, China.
Yan LiuSchool of Public Health, Jining Medical University, Jining, China.
The University of Melbourne · AUJining Medical University · CNThe University of Sydney · AUBinzhou Medical University · CNDalhousie University · CAPeking University · CNShandong University · CNTaian City Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cohort studyfirst-year university studentsmajor depressive disordernarcissistic personality traitsprotocadherin gene

Identifiers

PMID38384361
PMCPMC10879931
OpenAlexW4391612957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.